EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study

RSV-Belastung bei Frühgeborenen: Einfluss der Saison mit und ohne RSV-Immunprophylaxe in einer multizentrischen Studie

Keren Armoni Domany, Avigdor Mandelberg, Nitzan Burrack, Inbal Golan-Tripto, Kamal Masarweh, Michal Gur, Mika Rochman, Moria Be'er, Dario Prais, Merav Mor, Moran Weinberger Opek, Elias Nasrallah und 7 weitere

Pediatric Pulmonology · 2025-03 · 60 (3)

DOI: 10.1002/ppul.71022 ↗

Auf einen Blick

Bei Frühgeborenen mit 29–34 wGA war der Anteil der RSV-Hospitalisierungen in der Off-Season ohne Palivizumab höher als in der In-Season mit Prophylaxe. Die klinische Schwere war ähnlich.

Fragestellung

Unterscheidet sich die RSV-Hospitalisierungsbelastung bei Frühgeborenen mit 29–34 wGA zwischen Saisons mit und ohne routinemäßige Palivizumab-Prophylaxe?

Methode

Multizentrische retrospektive Studie in 11 Zentren in Israel; Vergleich von November–März mit routinemäßiger Palivizumab-Prophylaxe und April–Oktober ohne Prophylaxe; November 2017 bis August 2021.

Ergebnisse

3296 Infants in der In-Season und 1044 in der Off-Season. Anteil der 29–34 wGA: 7 % vs. 2,1 %; OR 2,6 (95 %-KI 1,8–3,9; p < 0,001). Schweregrad ähnlich.

Schlussfolgerung der Autor:innen

Die Autoren berichten eine deutlich höhere Hospitalisierungsproportion von 29–34-wGA-Infants in Saisons ohne Palivizumab-Prophylaxe und heben die Bedeutung künftiger Empfehlungen hervor, die diese Gruppe einschließen.

Kernaussagen

  • 29–34 wGA: 7 % vs. 2,1 % RSV-Hospitalisierungen
  • OR 2,6 (95 %-KI 1,8–3,9) für die Off-Season
  • Klinische Schwere zwischen den Perioden ähnlich

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Pulmonology, online erschienen am 05.03.2025. Verfasst von Keren Armoni Domany und 18 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Pulmonology Unit, Wolfson Medical Center, Holon, Israel. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Palivizumab, Antiviral Agents, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the Respiratory Syncytial Virus (RSV) hospitalization burden among 29–34 weeks gestational age (wGA) preterm infants between seasons with and without routine palivizumab prophylaxis, by utilizing the 2021 off‐season RSV surge.

Methods

This multi‐center retrospective study was conducted in 11 medical centers across Israel. We included infants < 1 year‐old, with wGA data, hospitalized with RSV infection from November 2017‐August 2021. National palivizumab compliance data were collected separately. We compared two periods: in‐season (November−March) with routine palivizumab prophylaxis as the reference, and off‐season (April−October) without prophylaxis as the primary risk factor. The primary outcome was the proportion of RSV hospitalizations in 29–34 wGA infants relative to total RSV admissions, calculated separately for each period. Secondary outcomes included clinical severity parameters.

Results

A total of 3296 infants were admitted during the RSV in‐season, and 1044 during the off‐season. National palivizumab compliance among eligible infants during the in‐season study years was 91%−95%. The proportion of 29−34 wGA infants was significantly higher during the off‐season compared to the in‐season period (7% vs. 2.1%, p < 0.001). In a multivariable logistic regression model, the odds of hospitalization for 29–34 wGA preemies were 2.6 times higher during the off‐season compared to the in‐season (95% CI: 1.8–3.9, p < 0.001), independent of demographic covariates. Clinical severity was similar between the two periods.

Conclusions

Our results revealed a significantly higher proportion of 29−34 wGA infants hospitalized during seasons without palivizumab prophylaxis compared to seasons with palivizumab prophylaxis. These findings highlight the importance of including 29−34 wGA infants into future RSV immunoprophylaxis recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsPalivizumabAntiviral AgentsHospitalizationHumansRetrospective StudiesMaleInfant, PrematureFemaleSeasonsInfant, NewbornIsraelInfantRespiratory Syncytial Virus, HumanGestational AgeRisk Factors

Stichwörter der Autor:innen

COVID‐19bronchiolitisimmunoprophylaxisrespiratory syncytial virus

Substanzen

PalivizumabAntiviral Agents

Autor:innen und Institutionen

  • Pediatric Pulmonology Unit, Wolfson Medical Center, Holon, Israel.
  • School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel.
  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Pediatric Pulmonary Unit, Soroka University Medical Center, Beer-Sheva, Israel.
  • Pediatric Pulmonary Institute and CF Center, The Ruth Rappaport Children's Hospital, Haifa, Israel.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Domany, K. A., Mandelberg, A., Burrack, N., Golan-Tripto, I., Masarweh, K., Gur, M., Rochman, M., Be'er, M., Prais, D., Mor, M., Opek, M. W., Nasrallah, E., Megged, O., Shatzman Steuerman, R., Stein, M., Steinberg, Z., Shehadeh, S., Glatman-Freedman, A., & Tasher, D. (2025). Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study. Pediatric Pulmonology, 60(3). https://doi.org/10.1002/ppul.71022

Vancouver

Domany KA, Mandelberg A, Burrack N, Golan-Tripto I, Masarweh K, Gur M, et al. Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study. Pediatric Pulmonology. 2025;60(3). doi:10.1002/ppul.71022

BibTeX
@article{Domany2025,
  author = {Domany, Keren Armoni and Mandelberg, Avigdor and Burrack, Nitzan and Golan-Tripto, Inbal and Masarweh, Kamal and Gur, Michal and Rochman, Mika and Be'er, Moria and Prais, Dario and Mor, Merav and Opek, Moran Weinberger and Nasrallah, Elias and Megged, Orli and Shatzman Steuerman, Rachel and Stein, Michal and Steinberg, Zohar and Shehadeh, Shereen and Glatman-Freedman, Aharona and Tasher, Diana},
  title = {Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study},
  journal = {Pediatric Pulmonology},
  year = {2025},
  volume = {60},
  number = {3},
  doi = {10.1002/ppul.71022}
}
Kostenlos starten →